Search research articles
Contact Us
Filters
Showing results (461-470 of 476) with videos related to
Page
of 48
Sort By:
Nature Communications
|
September 16, 2020
Giant magneto-optical responses in magnetic Weyl semimetal Co<sub>3</sub>Sn<sub>2</sub>S<sub>2</sub>
Y Okamura, S Minami, Y Kato, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society
|
June 1, 1979
[Clinical features of adult patients with acute lymphocytic leukemia according to immunological phenotypes of lymphoblasts (author's transl)]
K Kawashima, K Yamada, Y Morishima, et al.
Leukemia
|
September 26, 1997
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)
H Kiyoi, T Naoe, S Yokota, et al.
International Journal of Hematology
|
December 10, 1998
Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group
T Ueda, S Miyawaki, N Asou, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
April 1, 1979
[L-Asparaginase therapy in chemotherapy-resistant acute lymphocytic leukemias (author's transl)]
K Kawashima, Y Morishima, Y Kato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
January 1, 1980
[DCTP and DCMP two step therapy in acute non-lymphocytic leukemia (author's transl)]
Y Morishima, K Yamada, K Kawashima, et al.
International Journal of Hematology
|
September 25, 1999
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group
S Miyawaki, M Tanimoto, T Kobayashi, et al.
International Journal of Hematology
|
August 14, 1999
Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group
S Miyawaki, T Kobayashi, M Tanimoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group
T Kobayashi, S Miyawaki, M Tanimoto, et al.
Science Translational Medicine
|
April 14, 2017
Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis
Michael E Ward, Robert Chen, Hsin-Yi Huang, et al.
Page
of 48
Search research articles
Search
Showing results (461-470 of 476) with videos related to
Sort By:
Page
of 48
Nature Communications
|
September 16, 2020
Giant magneto-optical responses in magnetic Weyl semimetal Co<sub>3</sub>Sn<sub>2</sub>S<sub>2</sub>
Y Okamura, S Minami, Y Kato, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society
|
June 1, 1979
[Clinical features of adult patients with acute lymphocytic leukemia according to immunological phenotypes of lymphoblasts (author's transl)]
K Kawashima, K Yamada, Y Morishima, et al.
Leukemia
|
September 26, 1997
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)
H Kiyoi, T Naoe, S Yokota, et al.
International Journal of Hematology
|
December 10, 1998
Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group
T Ueda, S Miyawaki, N Asou, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
April 1, 1979
[L-Asparaginase therapy in chemotherapy-resistant acute lymphocytic leukemias (author's transl)]
K Kawashima, Y Morishima, Y Kato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
January 1, 1980
[DCTP and DCMP two step therapy in acute non-lymphocytic leukemia (author's transl)]
Y Morishima, K Yamada, K Kawashima, et al.
International Journal of Hematology
|
September 25, 1999
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group
S Miyawaki, M Tanimoto, T Kobayashi, et al.
International Journal of Hematology
|
August 14, 1999
Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group
S Miyawaki, T Kobayashi, M Tanimoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group
T Kobayashi, S Miyawaki, M Tanimoto, et al.
Science Translational Medicine
|
April 14, 2017
Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis
Michael E Ward, Robert Chen, Hsin-Yi Huang, et al.
Page
of 48